The Importance of Pathogen Identification in the Success of Treatment of Hospital Acquired Pneumonias

dc.authorwosid, osman/HRD-6024-2023
dc.authorwosid, Osman/AGR-7980-2022
dc.contributor.authorEdis, Ebru Cakir
dc.contributor.authorHatipoglu, Osman Nuri
dc.contributor.authorYilmam, Ilker
dc.contributor.authorEker, Alper
dc.contributor.authorTansel, Ozlem
dc.contributor.authorSut, Necdet
dc.date.accessioned2024-06-12T11:09:16Z
dc.date.available2024-06-12T11:09:16Z
dc.date.issued2010
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective: The aim of this study was to determine the effects of identification of the pathogens and specific and appropriate treatments, and the success of these treatments for subjects who acquired HAP non-ICU. Material and Method: The analyzed data was obtained from the records of 154 consecutive HAP patients who acquired pneumonia non-ICU. We investigated whether the factor was identified, whether patients received a specific therapy according to the results of a culture antibiogram, and whether the patients received appropriate antibiotics therapy initially. Results: When the groups treated specifically (n=78) and empirically (n=76) were compared, there were no significant differences between the clinical success rates. The difference was not significant between the group given an appropriate antibiotherapy initially (n=42) and the group whose initial therapy was changed according to the culture antibiogram after the factor was found (n=36). When the group given appropriate initial antibiotherapy (n=42) was compared with all the other patients (n=112), the difference between the clinical success rates was not significant. The most remarkable result of the study was the success rate being significantly higher in the group in which the pathogen could not be identified (n=66) compared with the group in (n=88) which the pathogen was identified (p=0.022). Conclusion: The clinical success rate was low in microorganism-caused HAPs with a potential for drug resistance and having the characteristic of developing rapid resistance, such as Acinetobacter spp. and Pseudomonas spp, even though specific treatment was administered. These results indicate that the prevention of infections that occur with such microorganisms is more important than the treatment.en_US
dc.identifier.doi10.5152/ttd.2010.25
dc.identifier.endpage159en_US
dc.identifier.issn2149-2530
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-78650408667en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage155en_US
dc.identifier.urihttps://doi.org/10.5152/ttd.2010.25
dc.identifier.urihttps://hdl.handle.net/20.500.14551/22749
dc.identifier.volume11en_US
dc.identifier.wosWOS:000421708700004en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherAvesen_US
dc.relation.ispartofTurkish Thoracic Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNon-ICU HAPen_US
dc.subjectMicrobiological Agenten_US
dc.subjectAppropriateen_US
dc.subjectTreatmenten_US
dc.subjectTreatment Successen_US
dc.titleThe Importance of Pathogen Identification in the Success of Treatment of Hospital Acquired Pneumoniasen_US
dc.typeArticleen_US

Dosyalar